Live Breaking News & Updates on Plaque Stabilization

Stay updated with breaking news from Plaque stabilization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elixir Medical To Present Randomized Clinical Dataset Featuring World's First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk ....

New Zealand , San Francisco , United States , Roxana Mehran , Stefan Verheye , Robertw Yeh , Motasim Sirhan , Mirvat Alasnag , Mark Webster , Ignacio Cruz Gonzalez , David Erlinge , Dynamx Hong Kong , Clinical Science Research , Clinical Science Research Sessions , Moscone Center , Innovation Program , Dynamx Coronary Bioadaptor Technology , Elixir Medical , Randomized Clinical Trial , Transcatheter Cardiovascular Therapeutics , Coronary Disease Diagnosis , Clinical Science Theater , Six Month Clinical , Imaging Results , Improved Outcomes Require , Presentation Theater ,

Elixir Medical Corporation: EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical's DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

First head-to-head randomized clinical trial (RCT) of DynamX Bioadaptor compared to Resolute Onyx DES shows statistically significant effectiveness in restoring vessel pulsatility, achieving significantly ....

United States , Erich Sandoval , Gewinn Nur , Motasim Sirhan , Elixir Medical Corporation , Development Of The Dynamx Bioadaptorthe , Dynamx Bioadaptor , Resolute Onyx , Target Lesion Failure , Drug Eluting Bioadaptor , Eluting Stent , Clinical Safety , Efficacy Results , Device Effectiveness , Vessel Function Results , Plaque Stabilization , Dynamx Bioadaptorthe , Elixir Medical , Dynamx Coronary Bioadaptor System , Medical Corporation ,

Early PCSK9 Inhibition in AMI Yields Plaque Regression

"Go early and go low" is an expert s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received alirobumab. ....

United States , Pamelab Morris , Bern Switz University Hospital , American College Of Cardiology , Boston Scientific , University Of South Carolina , European Society Of Cardiology , Novo Nordisk , University Hospital , American College , European Society , Plaque Stabilization , Preventive Cardiology , Medical University , South Carolina , Myocardial Infarction , Acute Myocardial Infarction , Alzheimers Disease , Lzheimer Disease , Amyloid Plaque , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Lipid Lowering Drugs , Rug Lipid Lowering , Acute Coronary Syndrome Acs , Cute Coronary Syndrome ,